Response to Wise et al. (Tiotropium safety in real life populations)

Br J Clin Pharmacol. 2016 Aug;82(2):564-5. doi: 10.1111/bcp.12970. Epub 2016 May 20.

Sven Schmiedl^{1

2}, Petra Thürmann^{1

2}, Rainald Fischer³, Dominik Rottenkolber^{4

5}, Marietta Rottenkolber^{6

7}

¹ Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten/Herdecke University, Witten.
² Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal.
³ Pneumologische Praxis Muenchen - Pasing, Munich.
⁴ Institute of Health Economics and Management, Ludwig-Maximilians-Universitaet Muenchen, Munich.
⁵ Helmholtz Zentrum Muenchen - German Research Center for Environmental Health, Member of the German Center for Lung Research, Neuherberg.
⁶ Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet Muenchen, Munich.
⁷ Diabetes Research Group, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany.

No abstract available

Publication types